Phase 1-3 development of an EORTC module assessing fertility issues and patient care needs

• Conditions: C00-C97; Malignant neoplasms

• Registration Number: DRKS00016024
• Lead Sponsor: Interdisziplinäres Tumorzentrum - CCCF - Stiftungsprofessur Selbsthilfeforschung

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-02-04
• Study Completion: 2021-04-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 82

Inclusion Criteria

Patients are eligible if they have / are
• signed the written informed consent to participate in the study
• a primary diagnosis of
o gynaecological cancer
o bladder cancer
o colorectal cancer
o testicular cancer
o prostate cancer
o breast cancer
o sarcoma and
o lymphoma
• Female patients > 18 years to 42 years
• Female patients in pre-menopause
• Male patients > 18 years
• Patients in any treatment with curative intention affecting fertility, focusing on
o Surgery
o Systemic therapy
o Radiotherapy
o Combined therapy (radiation, surgery, systemic treatment)

Exclusion Criteria

Patients with other than the above mentioned diagnoses and treatments, that are contradictionnairy to the inclusion criteria

Study & Design

• Study Type: observational
• Study Design: Not specified